Overview This report covers Parliamentary Questions (PQs) and Commission Answers published between Monday, 1 December 2025 […]
This week’s EU health policy developments: Debates on disease prevention, medicines regulation, health financing, access to care, and trade & food safety.
This week’s EU health policy developments: cross-border healthcare, regulation of medicines and pesticides, and oversight of national recovery funds.
This week’s EU health policy developments: regulation and transparency for medicines; prevention for public health; safety for food and chemicals
This week’s EU health policy: focus on workforce and access, regulation of medicines and data, AI governance, and environmental health and safety.
This week’s EU health policy developments: workforce challenges, public health prevention, medicines regulation, and environment-health links.
This week’s EU health policy developments span youth mental health, medical device and chemical regulation, and environmental health — with new Commission answers on Lyme diagnostics, ethanol classification, and EU-US tariff exemptions for pharmaceuticals.
This week’s EU health policy developments range from cancer prevention and tobacco control to medical device reform, pesticide regulation, and healthcare workforce resilience. The Commission confirmed plans to revise the Medical Devices Regulation by end-2025, detailed actions on e-cigarettes and vector-borne diseases, and addressed chemical safety, cross-border health risks, and emergency access in an evolving digital and environmental landscape.
This week’s EU health policy developments range from new mental health initiatives and the Pfizergate transparency case to waste disposal risks, Green Deal health impacts, and Mercosur trade concerns — all based on verified institutional sources.
Overview This report summarises key Parliamentary Questions (PQs) submitted during the June – July 2025 period. […]
